Nomic has partnered with Broad Clinical Labs to bring Omni 1000 into discovery and translational workflows.
After profiling ~1M samples, we’re expanding access and embedding our platform into multi-omic & translational research.
businesswire.com/news/home/2…
We’re pleased to welcome Byron Hewett to our Board of Directors!
As Nomic’s first Independent Director, Byron brings a wealth of operational and strategic expertise rooted in his experiences at the helm of companies like Somalogic.
Welcome, Byron!
businesswire.com/news/home/2…
Nomic Bio retweeted
We're thrilled to announce the successful closing of Lux 8 - our single largest fund to date with $1.15B in LP commitments! We will invest & fully fund the most ambitious founders building hard science & deep tech cos. Read the blog here and 🧵below:
luxcapital.com/lux8
Excited to announce the successful de novo synthesis of the world’s longest DNA #oligonucleotide ever reported to be produced in a single synthesis at 1005 bases. 🧬🧬🧬
Join the Early Access Program: ansabio.com/signup.
Full press release:
👇👇👇
bwnews.pr/3T9DPYw
Nomic Bio retweeted
Neat data alert! Together with @nomicbio we tested whether images and protein secretome profiles provide redundant info about cells’ response to various drugs
--> Nope! In our preliminary data, they appear complementary.
Nomic Bio retweeted
Really happy to announce that @nomicbio is now a Supporting Partner of the JUMP-Cell Painting Consortium.
Their nELISA platform for high throughput secreted protein profiling -> more juicy data for the world!
Details: bwnews.pr/3lMQQHN
& here: jump-cellpainting.broadinsti…
We are now providing our platform to the JUMP Cell Painting consortium, led by @DrAnneCarpenter at @broadinstitute. The nELISA will measure millions of secretome proteins as a complement to their cell-imaging tech to accelerate drug discovery.
Read more: bwnews.pr/3lMQQHN
We are now providing our platform to the JUMP Cell Painting consortium, led by @DrAnneCarpenter at @broadinstitute. The nELISA will measure millions of secretome proteins as a complement to their cell-imaging tech to accelerate drug discovery.
Read more: bwnews.pr/3lMQQHN
We are thrilled to announce our $17M Series A round led by @Lux_Capital! We are building the world’s highest throughput protein profiling platform, the nELISA, to make the proteome as broadly and easily accessible as the genome: bwnews.pr/3rKw1kf
We’re excited to share nplex biosciences’s new brand: Nomic Bio! As Nomic we’re advancing our goal to improve human health by providing scientists with the tools they need to access the human proteome at unprecedented scale & cost. Check out our new site: nomic.bio
We're looking for assay analysts, bio/nano-engineers, automation engineers, and data scientists with a knack for immunology! Come scale our nanotech-driven platform and transform modern drug discovery pipelines.
Check out all open opportunities here: angel.co/company/nplex-biosc…
We're thrilled to share news of our collaboration with McGill, @CQDM_Canada, and GSK. During this work, our nELISA platform will generate over 2 million protein data points at previously unheard-of throughput.
cqdm.org/en/news-and-events/…
Nomic Bio retweeted
Excited to be supporting @miladdag and the nplex Biosciences team! Great write-up from @alexiskold, @thisiszann and the team over at @2048vc on how nplex is accelerating the future of proteomics and supercharging the ways we discover and treat disease
[New Blog Post]: Our investment in nplex
2048.vc/blog/nplex
So excited to partner with @miladdag and incredible team @nplexbio to help power the next generation of proteomics.
@2048vc #vc #openforbusiness